Swedish company Elekta AB has received CE marking for its Clarity® 4D Monitoring system permitting European clinics to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. The device enables physicians to monitor the motion of the prostate with sub millimeter accuracy during the delivery of therapeutic radiation beams.
Elekta Receives CE Marking for Clarity 4D Monitoring (via
PR Newswire)
Soft tissue visualization system addresses organ motion challenges during prostate cancer radiotherapy CRAWLEY, England, July 19, 2013 /PRNewswire/ — Elekta has received CE marking for its Clarity® 4D Monitoring system permitting European clinics…
published: July 22, 2013 in: Approval/Clearance, Monitoring, Oncology